News

The Biomedical Research Institute of Barcelona (IIBB) leads the research network "Metabolic Diseases and Cancer", recently created for the identification of therapeutic targets.

The network approved by the Ministry of Science, Innovation and Universities, will be coordinated by Professor Jose Carlos Fernández-Checa and has the participation of four research groups linked t

Read More

A study demonstrates how mitochondrial oxidative stress regulates amyloid beta (Aβ) clearance by oxidative inactivation of the principal Aβ-degrading enzymes

Recent evidence indicates that decreased clearance of amyloid beta (Aβ) is the driving force leading to its toxic accumulation in late-onset (sporadic) Alzheimer’s disease.  Levels and activity of

Read More

A study by Dr. Vicenta Llorente-Cortés describes a biomarker that predicts the risk of developing cardiovascular diseases in advance.

The work, published in Atherosclerosis, shows that the levels of the sLRP1 protein in blood can indicate the risk of cardiovascular disease in people who do not present any symptoms.

Read More

CSIC in position 54 of the global top and position 12 of the European top according to the Nature Index 2019.

Read More

Dr. José C Fernández-Checa, from IIBB, has been awarded Doctor Honoris Causa by the Autonomous Metropolitan University of Mexico (UAM)

Read More

Descobreixen que el colesterol mitocondrial interfereix en l'acoblament dels supercomplejos respiratoris, responsables del consum d'oxigen en la cadena respiratòria mitocondrial.

El grup "Regulació mitocondrial de la mort cel·lular" ha caracteritzat un nou paper del colesterol en la disfunció mitocondrial.

Read More

A study published in Gastroenterology describes a new mitochondrial mediator in the hepatotoxicity induced by paracetamol.

Paracetamol is one of the most consumed analgesics in the world.

Read More

Pages